European Journal of Chemistry

A review on Nrf2 and antioxidant metalloproteins

Crossmark


Main Article Content

Abul Monsur Showkot Hossain
Qobilova Malika Qudratovna
Kholnazarov Bakhodir Azamovich
Ayumu Odaka
Daisuke Nakane
Takashiro Akitsu

Abstract

Nrf2 (nuclear factor erythroid 2–related factor 2) is a crucial transcription factor that regulates cellular defense against oxidative and electrophilic stress. Under basal conditions, Nrf2 binds to Keap1 (Kelch-like ECH-associated protein 1), which promotes its ubiquitination and degradation. The primary cellular response to oxidative or electrophilic stress is mediated through a redox-sensitive protein complex in which actin-associated Keap1 interacts with Nrf2. Upon exposure to stress-inducing agents, critical cysteine residues of Keap1 undergo modification, leading to conformational changes that disrupt the Keap1-Nrf2 interaction. As a result, Nrf2 escapes ubiquitination, stabilizes, and accumulates in the cytoplasm before translocating to the nucleus. Metalloproteins are well recognized as essential reservoirs and protective agents for trace metals such as iron, zinc, and copper, which are critical cofactors for numerous antioxidant enzymes. By controlling the expression of genes encoding metalloproteins and metal-binding proteins, Nrf2 contributes to the precise regulation of intracellular metal balance. This coordination is particularly important because, while essential metals are required for antioxidant defense, their dysregulation can promote oxidative damage through redox cycle reactions. Therefore, Nrf2-mediated regulation of metalloproteins represents a crucial interface between redox homeostasis and metal metabolism, reinforcing its central role in cellular protection.


icon graph This Abstract was viewed 5 times | icon graph Article PDF downloaded 1 times

How to Cite
(1)
Hossain, A. M. S.; Qudratovna, Q. M.; Azamovich, K. B.; Odaka, A.; Nakane, D.; Akitsu, T. A Review on Nrf2 and Antioxidant Metalloproteins. Eur. J. Chem. 2026, 17, 176-187.

Article Details

Share
Crossref - Scopus - Google - European PMC
References

[1]. Gao, B.; Doan, A.; Hybertson, B. M. The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders. Clin. Pharmacol. 2014, 6, 19-34.
https://doi.org/10.2147/CPAA.S35078

[2]. Itoh, K.; Chiba, T.; Takahashi, S.; Ishii, T.; Igarashi, K.; Katoh, Y.; Oyake, T.; Hayashi, N.; Satoh, K.; Hatayama, I.; Yamamoto, M.; Nabeshima, Y. An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements. Biochem. Biophys. Res. Commun. 1997, 236 (2), 313-322.
https://doi.org/10.1006/bbrc.1997.6943

[3]. Mcmahon, M.; Itoh, K.; Yamamoto, M.; Chanas, S. A.; Henderson, C. J.; Mclellan, L. I.; Wolf, C. R.; Cavin, C.; Hayes, J. D. The Cap 'n' Collar Basic Leucine Zipper Transcription Factor Nrf2 (NF-E2 p45-related Factor 2) Controls Both Constitutive and Inducible Expression of Intestinal Detoxification and Glutathione Biosynthetic Enzymes1. Cancer Res. 2001, 61, 3299-3307. https://aacrjournals.org/cancerres/article/61/8/3299/508626/The-Cap-n-Collar-Basic-Leucine-Zipper

[4]. Iida, K.; Itoh, K.; Kumagai, Y.; Oyasu, R.; Hattori, K.; Kawai, K.; Shimazui, T.; Akaza, H.; Yamamoto, M. Nrf2 Is Essential for the Chemopreventive Efficacy of Oltipraz against Urinary Bladder Carcinogenesis. Cancer Res. 2004, 64 (18), 6424-6431.
https://doi.org/10.1158/0008-5472.CAN-04-1906

[5]. Ramos-Gomez, M.; Kwak, M.; Dolan, P. M.; Itoh, K.; Yamamoto, M.; Talalay, P.; Kensler, T. W. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 2001, 98 (6), 3410-3415.
https://doi.org/10.1073/pnas.051618798

[6]. Kwak, M.; Kensler, T. W. Targeting NRF2 signaling for cancer chemoprevention. Toxicol. Appl. Pharmacol. 2010, 244 (1), 66-76.
https://doi.org/10.1016/j.taap.2009.08.028

[7]. Hayes, J. D.; Dinkova-Kostova, A. T. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem. Sci. 2014, 39 (4), 199-218.
https://doi.org/10.1016/j.tibs.2014.02.002

[8]. Kumar, H.; Kim, I.; More, S. V.; Kim, B.; Choi, D. Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases. Nat. Prod. Rep. 2014, 31 (1), 109-139.
https://doi.org/10.1039/C3NP70065H

[9]. Potter, J. D. The failure of cancer chemoprevention. Carcinogenesis 2014, 35 (5), 974-982.
https://doi.org/10.1093/carcin/bgu063

[10]. Mitsuishi, Y.; Motohashi, H.; Yamamoto, M. The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism. Front. Oncol. 2012, 2, 200.
https://doi.org/10.3389/fonc.2012.00200

[11]. Itoh, K.; Ye, P.; Matsumiya, T.; Tanji, K.; Ozaki, T. Emerging functional cross-talk between the Keap1-Nrf2 system and mitochondria. J. Clin. Biochem. Nutr. 2015, 56 (2), 91-97.
https://doi.org/10.3164/jcbn.14-134

[12]. Yamamoto, M.; Kensler, T. W.; Motohashi, H. The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis. Physiol. Rev. 2018, 98 (3), 1169-1203.
https://doi.org/10.1152/physrev.00023.2017

[13]. Forman, H. J.; Davies, K. J.; Ursini, F. How do nutritional antioxidants really work: Nucleophilic tone and para-hormesis versus free radical scavenging in vivo. Free Radic. Biol. Med. 2014, 66, 24-35.
https://doi.org/10.1016/j.freeradbiomed.2013.05.045

[14]. Baldwin, S. R.; Simon, R. H.; Grum, C. M.; Ketai, L. H.; Boxer, L. A.; Devall, L. J. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1986, 1, 11-14.
https://doi.org/10.1016/S0140-6736(86)91895-7

[15]. Christie, N.; Slutsky, A.; Freeman, B.; Tanswell, A. A Critical Role for Thiol, But Not ATP, Depletion in 95% O2-Mediated Injury of Preterm Pneumocytes in Vitro. Arch. Biochem. Biophys. 1994, 313 (1), 131-138.
https://doi.org/10.1006/abbi.1994.1369

[16]. Silva, D. M.; Aust, S. D. Ferritin and ceruloplasmin in oxidative damage: review and recent findings. Can. J. Physiol. Pharmacol. 1993, 71 (9), 715-720.
https://doi.org/10.1139/y93-107

[17]. Heffner, J. E.; Repine, J. E. Pulmonary Strategies of Antioxidant Defense. Am. Rev. Respir. Dis. 1989, 140 (2), 531-554.
https://doi.org/10.1164/ajrccm/140.2.531

[18]. Min, K. S.; Terano, Y.; Onosaka, S.; Tanaka, K. Induction of hepatic metallothionein by nonmetallic compounds associated with acute-phase response in inflammation. Toxicol. Appl. Pharmacol. 1991, 111, 152-162.
https://doi.org/10.1016/0041-008X(91)90144-4

[19]. Northway, W. H. Bronchopulmonary dysplasia: then and now. Arch. Dis. Child. 1990, 65 (10 Spec No), 1076-1081.
https://doi.org/10.1136/adc.65.10_Spec_No.1076

[20]. Rogers, J. T.; Bridges, K. R.; Durmowicz, G. P.; Glass, J.; Auron, P. E.; Munro, H. N. Translational control during the acute phase response. Ferritin synthesis in response to interleukin-1. J. Biol. Chem. 1990, 265, 14572-14578.
https://doi.org/10.1016/S0021-9258(18)77341-9

[21]. Sato, M.; Bremner, I. Oxygen free radicals and metallothionein. Free Radic. Biol. Med. 1993, 14, 325-337.
https://doi.org/10.1016/0891-5849(93)90029-T

[22]. Schapira, R. M.; Ghio, A. J.; Effros, R. M.; Morrisey, J.; Almagro, U. A.; Dawson, C. A.; Hacker, A. D. Hydroxyl Radical Production and Lung Injury in the Rat Following Silica or Titanium Dioxide Instillation In Vivo. Am. J. Respir. Cell Mol. Biol. 1995, 12 (2), 220-226.
https://doi.org/10.1165/ajrcmb.12.2.7865220

[23]. Sobonya, R. E.; Logvinoff, M. M.; Taussig, L. M.; Theriault, A. Morphometric Analysis of the Lung in Prolonged Bronchopulmonary Dysplasia. Pediatr. Res. 1982, 16 (11), 969-972.
https://doi.org/10.1203/00006450-198211000-00014

[24]. Stogner, S. W.; Payne, D. K. Oxygen Toxicity. Ann. Pharmacother. 1992, 26 (12), 1554-1562.
https://doi.org/10.1177/106002809202601214

[25]. Suzuki, T.; Yamamoto, M. Molecular basis of the Keap1-Nrf2 system. Free Radic. Biol. Med. 2015, 88, 93-100.
https://doi.org/10.1016/j.freeradbiomed.2015.06.006

[26]. Suzuki, T.; Yamamoto, M. Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress. J. Biol. Chem. 2017, 292 (41), 16817-16824.
https://doi.org/10.1074/jbc.R117.800169

[27]. Hayes, J. D.; McMahon, M.; Chowdhry, S.; Dinkova-Kostova, A. T. Cancer Chemoprevention Mechanisms Mediated Through the Keap1-Nrf2 Pathway. Antioxid. Redox Signal. 2010, 13 (11), 1713-1748.
https://doi.org/10.1089/ars.2010.3221

[28]. Pitoniak, A.; Bohmann, D. Mechanisms and functions of Nrf2 signaling in Drosophila. Free Rad. Biol. Med. 2015, 88, 302-313.
https://doi.org/10.1016/j.freeradbiomed.2015.06.020

[29]. Schäfer, M.; Werner, S. Nrf2-A regulator of keratinocyte redox signaling. Free Rad. Biol. Med. 2015, 88, 243-252.
https://doi.org/10.1016/j.freeradbiomed.2015.04.018

[30]. Huang, Y.; Li, W.; Su, Z.; Kong, A. T. The complexity of the Nrf2 pathway: beyond the antioxidant response. J. Nutr. Biochem. 2015, 26 (12), 1401-1413.
https://doi.org/10.1016/j.jnutbio.2015.08.001

[31]. Chushak, Y.; Clewell, R. A. An integrated approach to predict activators of NRF2 - the transcription factor for oxidative stress response. Artif. Intell. Life Sci. 2024, 5, 100097.
https://doi.org/10.1016/j.ailsci.2024.100097

[32]. Paunkov, A.; Chartoumpekis, D. V.; Ziros, P. G.; Gerasimos P. S. A Bibliometric Review of the Keap1/Nrf2 Pathway and its Related Antioxidant Compounds. Antioxidants 2019, 8 (9), 353.
https://doi.org/10.3390/antiox8090353

[33]. Sykiotis, G. P.; Bohmann, D. Stress-Activated Cap'n'collar Transcription Factors in Aging and Human Disease. Sci. Signal. 2010, 3 (112).
https://doi.org/10.1126/scisignal.3112re3

[34]. Johnson, D. A.; Johnson, J. A. Nrf2-a therapeutic target for the treatment of neurodegenerative diseases. Free Rad. Biol. Med. 2015, 88, 253-267.
https://doi.org/10.1016/j.freeradbiomed.2015.07.147

[35]. Cuadrado, A.; Rojo, A. I.; Wells, G.; Hayes, J. D.; Cousin, S. P.; Rumsey, W. L.; Attucks, O. C.; Franklin, S.; Levonen, A.; Kensler, T. W.; Dinkova-Kostova, A. T. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat. Rev. Drug. Discov. 2019, 18 (4), 295-317.
https://doi.org/10.1038/s41573-018-0008-x

[36]. Nezu, M.; Suzuki, N.; Yamamoto, M. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression. Am. J. Nephrol. 2017, 45 (6), 473-483.
https://doi.org/10.1159/000475890

[37]. Uruno, A.; Yagishita, Y.; Yamamoto, M. The Keap1-Nrf2 system and diabetes mellitus. Arch. Biochem. Biophys. 2015, 566, 76-84.
https://doi.org/10.1016/j.abb.2014.12.012

[38]. Suzuki, T.; Motohashi, H.; Yamamoto, M. Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol. Sci. 2013, 34 (6), 340-346.
https://doi.org/10.1016/j.tips.2013.04.005

[39]. Taguchi, K.; Yamamoto, M. The KEAP1-NRF2 System in Cancer. Front. Oncol. 2017, 7, 85 https://doi.org/10.3389/fonc.2017.00085.
https://doi.org/10.3389/fonc.2017.00085

[40]. Yaroslav, C.; Rebecca, A. C. An integrated approach to predict activators of NRF2 - the transcription factor for oxidative stress response. Arti. Intel. Life Sci. 2024, 5, 100097.
https://doi.org/10.1016/j.ailsci.2024.100097

[41]. Bauman, J. E.; Zang, Y.; Sen, M.; Li, C.; Wang, L.; Egner, P. A.; Fahey, J. W.; Normolle, D. P.; Grandis, J. R.; Kensler, T. W.; Johnson, D. E. Prevention of Carcinogen-Induced Oral Cancer by Sulforaphane. Cancer Prev. Res. 2016, 9 (7), 547-557.
https://doi.org/10.1158/1940-6207.CAPR-15-0290

[42]. Yang, L.; Palliyaguru, D. L.; Kensler, T. W. Frugal chemoprevention: targeting Nrf2 with foods rich in sulforaphane. Semin. Oncology 2016, 43 (1), 146-153.
https://doi.org/10.1053/j.seminoncol.2015.09.013

[43]. Singh, A.; Misra, V.; Thimmulappa, R. K.; Lee, H.; Ames, S.; Hoque, M. O.; Herman, J. G.; Baylin, S. B.; Sidransky, D.; Gabrielson, E.; Brock, M. V.; Biswal, S. Dysfunctional KEAP1-NRF2 Interaction in Non-Small-Cell Lung Cancer. PLoS Med. 2006, 3 (10), e420.
https://doi.org/10.1371/journal.pmed.0030420

[44]. Chartoumpekis, D. V.; Yagishita, Y.; Fazzari, M.; Palliyaguru, D. L.; Rao, U. N.; Zaravinos, A.; Khoo, N. K.; Schopfer, F. J.; Weiss, K. R.; Michalopoulos, G. K.; Sipula, I.; O'Doherty, R. M.; Kensler, T. W.; Wakabayashi, N. Nrf2 prevents Notch-induced insulin resistance and tumorigenesis in mice. JCI. Insight. 2018, 3 (5).
https://doi.org/10.1172/jci.insight.97735

[45]. Yagishita, Y.; Uruno, A.; Fukutomi, T.; Saito, R.; Saigusa, D.; Pi, J.; Fukamizu, A.; Sugiyama, F.; Takahashi, S.; Yamamoto, M. Nrf2 Improves Leptin and Insulin Resistance Provoked by Hypothalamic Oxidative Stress. Cell Rep. 2017, 18 (8), 2030-2044.
https://doi.org/10.1016/j.celrep.2017.01.064

[46]. Uruno, A.; Furusawa, Y.; Yagishita, Y.; Fukutomi, T.; Muramatsu, H.; Negishi, T.; Sugawara, A.; Kensler, T. W.; Yamamoto, M. The Keap1-Nrf2 System Prevents Onset of Diabetes Mellitus. Mol. Cell. Biol. 2013, 33 (15), 2996-3010.
https://doi.org/10.1128/MCB.00225-13

[47]. Pergola, P. E.; Raskin, P.; Toto, R. D.; Meyer, C. J.; Huff, J. W.; Grossman, E. B.; Krauth, M.; Ruiz, S.; Audhya, P.; Christ-Schmidt, H.; Wittes, J.; Warnock, D. G.; BEAM Study Investigators Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N. Engl. J. Med. 2011, 365, 327-336.
https://doi.org/10.1056/NEJMoa1105351

[48]. de Zeeuw, D.; Akizawa, T.; Audhya, P.; Bakris, G. L.; Chin, M.; Christ-Schmidt, H.; Goldsberry, A.; Houser, M.; Krauth, M.; Lambers Heerspink, H. J.; McMurray, J. J.; Meyer, C. J.; Parving, H.; Remuzzi, G.; Toto, R. D.; Vaziri, N. D.; Wanner, C.; Wittes, J.; Wrolstad, D.; Chertow, G. M. Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease. N. Engl. J. Med. 2013, 369 (26), 2492-2503.
https://doi.org/10.1056/NEJMoa1306033

[49]. Itoh, K.; Wakabayashi, N.; Katoh, Y.; Ishii, T.; Igarashi, K.; Engel, J. D.; Yamamoto, M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes. Dev. 1999, 13 (1), 76-86.
https://doi.org/10.1101/gad.13.1.76

[50]. Rajesh, K.; Thimmulappa, K. H.; Mai, S.; Srisuma, T. W.; Kensler, M. Shyam Biswal; Identification of Nrf2-regulated Genes Induced by the Chemopreventive Agent Sulforaphane by Oligonucleotide Microarray1. Cancer Res. 2002, 62, 5196-5203. https://aacrjournals.org/cancerres/article/62/18/5196/509134/Identification-of-Nrf2-regulated-Genes-Induced-by

[51]. Taguchi, K.; Maher, J. M.; Suzuki, T.; Kawatani, Y.; Motohashi, H.; Yamamoto, M. Genetic Analysis of Cytoprotective Functions Supported by Graded Expression of Keap1. Mol. Cell. Biol. 2010, 30 (12), 3016-3026.
https://doi.org/10.1128/MCB.01591-09

[52]. Okawa, H.; Motohashi, H.; Kobayashi, A.; Aburatani, H.; Kensler, T. W.; Yamamoto, M. Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem. Biophys. Res. Commun. 2006, 339 (1), 79-88.
https://doi.org/10.1016/j.bbrc.2005.10.185

[53]. Yates, M. S.; Kwak, M.; Egner, P. A.; Groopman, J. D.; Bodreddigari, S.; Sutter, T. R.; Baumgartner, K. J.; Roebuck, B.; Liby, K. T.; Yore, M. M.; Honda, T.; Gribble, G. W.; Sporn, M. B.; Kensler, T. W. Potent Protection against Aflatoxin-Induced Tumorigenesis through Induction of Nrf2-Regulated Pathways by the Triterpenoid 1-[2-Cyano-3-,12-Dioxooleana-1,9(11)-Dien-28-Oyl]Imidazole. Cancer Res. 2006, 66 (4), 2488-2494.
https://doi.org/10.1158/0008-5472.CAN-05-3823

[54]. Slocum, S. L.; Skoko, J. J.; Wakabayashi, N.; Aja, S.; Yamamoto, M.; Kensler, T. W.; Chartoumpekis, D. V. Keap1/Nrf2 pathway activation leads to a repressed hepatic gluconeogenic and lipogenic program in mice on a high-fat diet. Arch. Biochem. Biophys. 2016, 591, 57-65.
https://doi.org/10.1016/j.abb.2015.11.040

[55]. Tan, R. J.; Chartoumpekis, D. V.; Rush, B. M.; Zhou, D.; Fu, H.; Kensler, T. W.; Liu, Y. Keap1 hypomorphism protects against ischemic and obstructive kidney disease. Sci. Rep. 2016, 6 (1), 36185 https://doi.org/10.1038/srep36185.
https://doi.org/10.1038/srep36185

[56]. Dinkova-Kostova, A. T.; Fahey, J. W.; Kostov, R. V.; Kensler, T. W. KEAP1 and done? Targeting the NRF2 pathway with sulforaphane. Trends Food Sci. Tech. 2017, 69, 257-269.
https://doi.org/10.1016/j.tifs.2017.02.002

[57]. Palliyaguru, D. L.; Yuan, J.; Kensler, T. W.; Fahey, J. W. Isothiocyanates: Translating the Power of Plants to People. Molecular. Nutrition. Food. Res. 2018, 62 (18), e1700965.
https://doi.org/10.1002/mnfr.201700965

[58]. Kensler, T. W.; Egner, P. A.; Agyeman, A. S.; Visvanathan, K.; Groopman, J. D.; Chen, J.; Chen, T.; Fahey, J. W.; Talalay, P. Keap1-Nrf2 Signaling: A Target for Cancer Prevention by Sulforaphane. Top. Curr. Chem. 2012, 163-177.
https://doi.org/10.1007/128_2012_339

[59]. Egner, P. A.; Chen, J.; Zarth, A. T.; Ng, D. K.; Wang, J.; Kensler, K. H.; Jacobson, L. P.; Muñoz, A.; Johnson, J. L.; Groopman, J. D.; Fahey, J. W.; Talalay, P.; Zhu, J.; Chen, T.; Qian, G.; Carmella, S. G.; Hecht, S. S.; Kensler, T. W. Rapid and Sustainable Detoxication of Airborne Pollutants by Broccoli Sprout Beverage: Results of a Randomized Clinical Trial in China. Cancer Prev. Res. 2014, 7 (8), 813-823.
https://doi.org/10.1158/1940-6207.CAPR-14-0103

[60]. Sykiotis, G. P.; Habeos, I. G.; Samuelson, A. V.; Bohmann, D. The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation. Curr. Opin. Clin. Nutr. Metab. Car. 2011, 14 (1), 41-48.
https://doi.org/10.1097/MCO.0b013e32834136f2

[61]. Axelsson, A. S.; Tubbs, E.; Mecham, B.; Chacko, S.; Nenonen, H. A.; Tang, Y.; Fahey, J. W.; Derry, J. M.; Wollheim, C. B.; Wierup, N.; Haymond, M. W.; Friend, S. H.; Mulder, H.; Rosengren, A. H. Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. Sci. Transl. Med. 2017, 9 (394), eaah4477.
https://doi.org/10.1126/scitranslmed.aah4477

[62]. Gold, R.; Kappos, L.; Arnold, D. L.; Bar-Or, A.; Giovannoni, G.; Selmaj, K.; Tornatore, C.; Sweetser, M. T.; Yang, M.; Sheikh, S. I.; Dawson, K. T. Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis. N. Engl. J. Med. 2012, 367 (12), 1098-1107.
https://doi.org/10.1056/NEJMoa1114287

[63]. Ngo, V.; Duennwald, M. L. Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease. Antioxidants 2022, 11 (12), 2345.
https://doi.org/10.3390/antiox11122345

[64]. Apel, K.; Hirt, H. Reactive oxygen species: Metabolism, Oxidative Stress, and Signal Transduction. Annu. Rev. Plant. Biol. 2004, 55 (1), 373-399.
https://doi.org/10.1146/annurev.arplant.55.031903.141701

[65]. Reuter, S.; Gupta, S. C.; Chaturvedi, M. M.; Aggarwal, B. B. Oxidative stress, inflammation, and cancer: How are they linked?. Free Rad. Biol. Med. 2010, 49 (11), 1603-1616.
https://doi.org/10.1016/j.freeradbiomed.2010.09.006

[66]. Alfadda, A. A.; Sallam, R. M. Reactive Oxygen Species in Health and Disease. J. Biomed. Biotechn. 2012, 2012, 1-14, 936486.
https://doi.org/10.1155/2012/936486

[67]. Asmat, U.; Abad, K.; Ismail, K. Diabetes mellitus and oxidative stress-A concise review. Saudi. Pharmaceut. J. 2016, 24 (5), 547-553.
https://doi.org/10.1016/j.jsps.2015.03.013

[68]. Liguori, I.; Russo, G.; Curcio, F.; Bulli, G.; Aran, L.; Della-Morte, D.; Gargiulo, G.; Testa, G.; Cacciatore, F.; Bonaduce, D.; Abete, P. Oxidative stress, aging, and diseases. CIA Clin. Interv. Aging. 2018, 13, 757-772.
https://doi.org/10.2147/CIA.S158513

[69]. Barnham, K. J.; Masters, C. L.; Bush, A. I. Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug. Discov. 2004, 3 (3), 205-214.
https://doi.org/10.1038/nrd1330

[70]. Halliwell, B.; Gutteridge, J. M. The definition and measurement of antioxidants in biological systems. Free Radic. Biol. Med. 1995, 18, 125-126.
https://doi.org/10.1016/0891-5849(95)91457-3

[71]. Rushmore, T. H.; Morton, M. R.; Pickett, C. B. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 1991, 266, 11632-11639.
https://doi.org/10.1016/S0021-9258(18)99004-6

[72]. Nioi, P.; Mcmahon, M.; Itoh, K.; Yamamoto, M.; Hayes, J. D. Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. Biochem. J. 2003, 374 (2), 337-348.
https://doi.org/10.1042/bj20030754

[73]. Chan, K.; Han, X.; Kan, Y. W. An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen. Proc. Natl. Acad. Sci. U.S.A. 2001, 98 (8), 4611-4616.
https://doi.org/10.1073/pnas.081082098

[74]. Enomoto, A. High Sensitivity of Nrf2 Knockout Mice to Acetaminophen Hepatotoxicity Associated with Decreased Expression of ARE-Regulated Drug Metabolizing Enzymes and Antioxidant Genes. Toxicol. Sci. 2001, 59 (1), 169-177.
https://doi.org/10.1093/toxsci/59.1.169

[75]. Moi, P.; Chan, K.; Asunis, I.; Cao, A.; Kan, Y. W. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc. Natl. Acad. Sci. U.S.A. 1994, 91 (21), 9926-9930.
https://doi.org/10.1073/pnas.91.21.9926

[76]. Nguyen, T.; Sherratt, P. J.; Huang, H.; Yang, C. S.; Pickett, C. B. Increased Protein Stability as a Mechanism That Enhances Nrf2-mediated Transcriptional Activation of the Antioxidant Response Element. J. Biol. Chem. 2003, 278 (7), 4536-4541.
https://doi.org/10.1074/jbc.M207293200

[77]. Kobayashi, A.; Kang, M.; Okawa, H.; Ohtsuji, M.; Zenke, Y.; Chiba, T.; Igarashi, K.; Yamamoto, M. Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2. Mol. Cell. Biol. 2004, 24 (16), 7130-7139.
https://doi.org/10.1128/MCB.24.16.7130-7139.2004

[78]. McMahon, M.; Itoh, K.; Yamamoto, M.; Hayes, J. D. Keap1-dependent Proteasomal Degradation of Transcription Factor Nrf2 Contributes to the Negative Regulation of Antioxidant Response Element-driven Gene Expression. J. Biol. Chem. 2003, 278 (24), 21592-21600.
https://doi.org/10.1074/jbc.M300931200

[79]. Zhang, D. D.; Hannink, M. Distinct Cysteine Residues in Keap1 Are Required for Keap1-Dependent Ubiquitination of Nrf2 and for Stabilization of Nrf2 by Chemopreventive Agents and Oxidative Stress. Mol. Cell. Biol. 2003, 23 (22), 8137-8151.
https://doi.org/10.1128/MCB.23.22.8137-8151.2003

[80]. Dinkova-Kostova, A. T.; Holtzclaw, W. D.; Cole, R. N.; Itoh, K.; Wakabayashi, N.; Katoh, Y.; Yamamoto, M.; Talalay, P. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. U.S.A. 2002, 99 (18), 11908-11913.
https://doi.org/10.1073/pnas.172398899

[81]. Wakabayashi, N.; Dinkova-Kostova, A. T.; Holtzclaw, W. D.; Kang, M.; Kobayashi, A.; Yamamoto, M.; Kensler, T. W.; Talalay, P. Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers. Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (7), 2040-2045.
https://doi.org/10.1073/pnas.0307301101

[82]. Kobayashi, A.; Kang, M.; Watai, Y.; Tong, K. I.; Shibata, T.; Uchida, K.; Yamamoto, M. Oxidative and Electrophilic Stresses Activate Nrf2 through Inhibition of Ubiquitination Activity of Keap1. Mol. Cell. Biol. 2006, 26 (1), 221-229.
https://doi.org/10.1128/MCB.26.1.221-229.2006

[83]. Tang, L.; He, D.; Su, B. Nrf2: A critical participant in regulation of apoptosis, ferroptosis, and autophagy in gastric cancer. Acta Histochemica 2024, 126 (8), 152203.
https://doi.org/10.1016/j.acthis.2024.152203

[84]. DeNicola, G. M.; Karreth, F. A.; Humpton, T. J.; Gopinathan, A.; Wei, C.; Frese, K.; Mangal, D.; Yu, K. H.; Yeo, C. J.; Calhoun, E. S.; Scrimieri, F.; Winter, J. M.; Hruban, R. H.; Iacobuzio-Donahue, C.; Kern, S. E.; Blair, I. A.; Tuveson, D. A. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 2011, 475 (7354), 106-109.
https://doi.org/10.1038/nature10189

[85]. Chen, C.-C.; Chu, C.-B.; Liu, K.-J.; Huang, C.-Y. F.; Chang, J.-Y.; Pan, W.-Y.; Chen, H.-H.; Cheng, Y.-H.; Lee, K.-D.; Chen, M.-F.; Kuo, C.-C.; Chen, L.-T. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification. Biochem. Pharmacol. 2013, 86, 872-887.
https://doi.org/10.1016/j.bcp.2013.07.025

[86]. Li, W.; Kong, A. Molecular mechanisms of Nrf2‐mediated antioxidant response. Mol. Carcinogenesis 2008, 48 (2), 91-104.
https://doi.org/10.1002/mc.20465

[87]. Zhang, D. D.; Lo, S.; Sun, Z.; Habib, G. M.; Lieberman, M. W.; Hannink, M. Ubiquitination of Keap1, a BTB-Kelch Substrate Adaptor Protein for Cul3, Targets Keap1 for Degradation by a Proteasome-independent Pathway. J. Biol. Chem. 2005, 280 (34), 30091-30099.
https://doi.org/10.1074/jbc.M501279200

[88]. Yuan, X.; Xu, C.; Pan, Z.; Keum, Y.; Kim, J.; Shen, G.; Yu, S.; Oo, K. T.; Ma, J.; Kong, A. T. Butylated hydroxyanisole regulates ARE‐mediated gene expression via Nrf2 coupled with ERK and JNK signaling pathway in HepG2 cells. Mol. Carcinogenesis 2006, 45 (11), 841-850.
https://doi.org/10.1002/mc.20234

[89]. Purdom-Dickinson, S. E.; Sheveleva, E. V.; Sun, H.; Chen, Q. M. Translational Control of Nrf2 Protein in Activation of Antioxidant Response by Oxidants. Mol. Pharmacol. 2007, 72 (4), 1074-1081.
https://doi.org/10.1124/mol.107.035360

[90]. Ma, Q. Role of Nrf2 in Oxidative Stress and Toxicity. Annu. Rev. Pharmacol. Toxicol. 2013, 53 (1), 401-426.
https://doi.org/10.1146/annurev-pharmtox-011112-140320

[91]. Niture, S. K.; Khatri, R.; Jaiswal, A. K. Regulation of Nrf2-an update. Free Rad. Biol. Med. 2014, 66, 36-44.
https://doi.org/10.1016/j.freeradbiomed.2013.02.008

[92]. Osburn, W. O.; Wakabayashi, N.; Misra, V.; Nilles, T.; Biswal, S.; Trush, M. A.; Kensler, T. W. Nrf2 regulates an adaptive response protecting against oxidative damage following diquat-mediated formation of superoxide anion. Arch. Biochem. Biophys. 2006, 454 (1), 7-15.
https://doi.org/10.1016/j.abb.2006.08.005

[93]. Wilson, L. A.; Gemin, A.; Espiritu, R.; Singh, G. ets‐1 is transcriptionally up‐regulated by H2O2via an antioxidant response element. FASEB. J. 2005, 19 (14), 2085-2087.
https://doi.org/10.1096/fj.05-4401fje

[94]. Itoh, K.; Tong, K. I.; Yamamoto, M. Molecular mechanism activating nrf2-keap1 pathway in regulation of adaptive response to electrophiles. Free Rad. Biol. Med. 2004, 36 (10), 1208-1213.
https://doi.org/10.1016/j.freeradbiomed.2004.02.075

[95]. Dhakshinamoorthy, S.; Porter, A. G. Nitric Oxide-induced Transcriptional Up-regulation of Protective Genes by Nrf2 via the Antioxidant Response Element Counteracts Apoptosis of Neuroblastoma Cells. J. Biol. Chem. 2004, 279 (19), 20096-20107.
https://doi.org/10.1074/jbc.M312492200

[96]. Dinkova-Kostova, A. T.; Holtzclaw, W. D.; Kensler, T. W. The Role of Keap1 in Cellular Protective Responses. Chem. Res. Toxicol. 2005, 18 (12), 1779-1791.
https://doi.org/10.1021/tx050217c

[97]. Katoh, Y.; Iida, K.; Kang, M.; Kobayashi, A.; Mizukami, M.; Tong, K. I.; McMahon, M.; Hayes, J. D.; Itoh, K.; Yamamoto, M. Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome. Arch. Biochem. Biophys. 2005, 433 (2), 342-350.
https://doi.org/10.1016/j.abb.2004.10.012

[98]. Katoh, Y.; Itoh, K.; Yoshida, E.; Miyagishi, M.; Fukamizu, A.; Yamamoto, M. Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription. Genes Cells 2001, 6 (10), 857-868.
https://doi.org/10.1046/j.1365-2443.2001.00469.x

[99]. Nioi, P.; Nguyen, T.; Sherratt, P. J.; Pickett, C. B. The Carboxy-Terminal Neh3 Domain of Nrf2 Is Required for Transcriptional Activation. Mol. Cell. Biol. 2005, 25 (24), 10895-10906.
https://doi.org/10.1128/MCB.25.24.10895-10906.2005

[100]. McMahon, M.; Thomas, N.; Itoh, K.; Yamamoto, M.; Hayes, J. D. Redox-regulated Turnover of Nrf2 Is Determined by at Least Two Separate Protein Domains, the Redox-sensitive Neh2 Degron and the Redox-insensitive Neh6 Degron. J. Biol. Chem. 2004, 279 (30), 31556-31567.
https://doi.org/10.1074/jbc.M403061200

[101]. Lo, S.; Li, X.; Henzl, M. T.; Beamer, L. J.; Hannink, M. Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling. EMBO. J. 2006, 25 (15), 3605-3617.
https://doi.org/10.1038/sj.emboj.7601243

[102]. Fita, I.; Rossmann, M. G. The active center of catalase. J. Mol. Biol. 1985, 185, 21-37.
https://doi.org/10.1016/0022-2836(85)90180-9

[103]. Jung, K.; Kwak, M. The Nrf2 System as a Potential Target for the Development of Indirect Antioxidants. Molecules 2010, 15 (10), 7266-7291.
https://doi.org/10.3390/molecules15107266

[104]. Schneider, Y.; Vincent, F.; Duranton, B.; Badolo, L.; Gossé, F.; Bergmann, C.; Seiler, N.; Raul, F. Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett. 2000, 158, 85-91.
https://doi.org/10.1016/S0304-3835(00)00511-5

[105]. Brigelius-Flohé, R. Tissue-specific functions of individual glutathione peroxidases. Free Radic. Biol. Med. 1999, 27, 951-965.
https://doi.org/10.1016/S0891-5849(99)00173-2

[106]. Forgione, M. A.; Cap, A.; Liao, R.; Moldovan, N. I.; Eberhardt, R. T.; Lim, C. C.; Jones, J.; Goldschmidt-Clermont, P. J.; Loscalzo, J. Heterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac function and structure: Abnormalities in vascular and cardiac function and structure. Circulation 2002, 106, 1154-1158.
https://doi.org/10.1161/01.CIR.0000026820.87824.6A

[107]. Talalay, P.; De Long, M. J.; Prochaska, H. J. Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 1988, 85 (21), 8261-8265.
https://doi.org/10.1073/pnas.85.21.8261

[108]. Kobayashi, M.; Li, L.; Iwamoto, N.; Nakajima-Takagi, Y.; Kaneko, H.; Nakayama, Y.; Eguchi, M.; Wada, Y.; Kumagai, Y.; Yamamoto, M. The Antioxidant Defense System Keap1-Nrf2 Comprises a Multiple Sensing Mechanism for Responding to a Wide Range of Chemical Compounds. Mol. Cell. Biol. 2009, 29 (2), 493-502.
https://doi.org/10.1128/MCB.01080-08

[109]. Holland, R.; Hawkins, A. E.; Eggler, A. L.; Mesecar, A. D.; Fabris, D.; Fishbein, J. C. Prospective type 1 and type 2 disulfides of Keap1 protein. Chem. Res. Toxicol. 2008, 21, 2051-2060.
https://doi.org/10.1021/tx800226m

Most read articles by the same author(s)

Most read articles by the same author(s)

TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
License Terms
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

License Terms

by-nc

Copyright © 2026 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).